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ABSTRACT
Mitochondrial DNA (mtDNA) defects cause debilitat-
ing metabolic disorders for which there is no
effective treatment. Patients suffering from these
diseases often harbour both a wild-type and a
mutated subpopulation of mtDNA, a situation
termed heteroplasmy. Understanding mtDNA repair
mechanisms could facilitate the development of
novel therapies to combat these diseases. In par-
ticular, mismatch repair activity could potentially be
used to repair pathogenic mtDNA mutations exist-
ing in the heteroplasmic state if heteroduplexes
could be generated. To date, however, there has
been no compelling evidence for such a repair
activity in mammalian mitochondria. We now report
evidence consistent with a mismatch repair
capability in mammalian mitochondria that exhibits
some characteristics of the nuclear pathway. A
repair assay utilising a nicked heteroduplex
substrate with a GT or a GG mismatch in the
b-galactosidase reporter gene was used to test the
repair potential of different lysates. A low level
repair activity was identi®ed in rat liver mitochon-
drial lysate that showed no strand bias. The
activity was mismatch-selective, bi-directional, ATP-
dependent and EDTA-sensitive. Western analysis
using antibody to MSH2, a key nuclear mismatch
repair system (MMR) protein, showed no cross-
reacting species in mitochondrial lysate. A hypo-
thesis to explain the molecular mechanism of mito-
chondrial MMR in the light of these observations is
discussed.
INTRODUCTION
Mitochondria are ubiquitous organelles found in all nucleated
mammalian cells. They house the enzyme complexes respon-
sible for coupling respiration to the generation of ATP and
play a central role in several apoptotic pathways (1). In
addition to harbouring metabolic enzymes, mitochondria also
contain numerous copies of their own genome, mtDNA, that
encode components of the oxidative phosphorylation
machinery. Diseases arising from mtDNA defects are varied
and debilitating (2). There is no effective treatment for these
disorders and new therapies are actively being sought. Many
patients harbour populations of both mutated and wild-type
mtDNA (a condition termed heteroplasmy), with the mutation
often being recessive. One possible way of treating these
patients would therefore be to manipulate the balance between
mutated and wild-type molecules, allowing the wild-type to
propagate at the expense of the mutated genome. A method for
the selective targeting of mutated mtDNA has been designed,
with the aim of inhibiting replication (3,4). An additional
long-term approach would be to import wild-type single-
stranded DNA oligomers targeted to the mtDNA mutation,
which, on hybridisation to the single-stranded mtDNA during
replication, would generate a heteroduplex. Endogenous
DNA mismatch repair machinery would then recognise the
mismatch, substituting the pathogenic nucleotide with the
wild-type counterpart.
But does such a repair activity exist in mammalian
mitochondria? Nuclear DNA is protected by a variety of
repair systems (5,6). Some pathways, such as the nucleotide
excision repair (NER) pathway, are non-speci®c; they detect
lesions arising from distortions of the DNA helix (7).
Alternatively, other enzymes target and repair particular
lesions. Base excision repair (BER) uses a speci®c glycosyl-
ase, then an AP-endonuclease or AP-lyase to excise the lesion
(8). For example, thymine-DNA glycosylase repairs T/G
mispairs arising from the spontaneous deamination of cytosine
to uracil, and 5-methylcytosine to thymine (9). Errors of
replication that result in a mismatch or small loop are detected
and corrected by the mismatch repair system (MMR), which
also functions in homologous recombination. The best-
characterised MMR pathway is the bacterial methyl-directed
MutHLS system (10). Homologues of MutS andMutL (but not
MutH) have been identi®ed in most eukaryotes as several
isoforms (11). In the yeast Saccharomyces cerevisiae, one of
the six MutS isoforms, MSH1, encodes a mitochondrial
protein that binds base mismatches (12). Null strains show
gross mtDNA rearrangements, but a homologue of MSH1 has
not been found in mammals.
mtDNA is close to the respiratory chain, a major source of
reactive oxygen intermediates, and is unbound by histones,
consistent with reports suggesting it is subject to more damage
than nuclear DNA (13). Several enzymes involved in
mitochondrial BER have been reported (14), however NER
has not been demonstrated in mammalian mitochondria. To
date, it is still unclear whether mammalian mitochondria
harbour a functional MMR activity. Here, we seek to determine
whether mitochondrial extracts can repair mismatches using a
well-characterised, robust, repair assay. Heteroduplexes were
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engineered from bacteriophage DNA carrying the reporter gene
b-galactosidase, which, when coupled to a bacterial read-out
system, was used to measure repair activity for various extracts.
A signi®cant MMR activity was detected in puri®ed rat
mitochondrial lysates, which repaired a single G-T or G-G
mismatch. This activity was sensitive to EDTA, required ATP,
was insensitive to aphidicolin and did not require the ubiquitous
mismatch repair enzyme, MSH2. No strand bias could be
detected. One hypothesis is presented to explain the potential
role of MMR in mitochondria.
MATERIALS AND METHODS
Materials
Escherichia coli strains NR9099, NR9162 and CSH50 rele-
vant genotypes are described in the repair assay (15). M13mp2
phage derivatives carrying TGA89 and TCA89 mutations in
the b-galactosidase gene were a kind gift from T. A. Kunkel
(N.I.E.H.S., NC, USA). Restriction enzymes were from Roche
or New England Biolabs.
Speci®c reagents
Aphidicolin and ATP sulfurylase were from Sigma, complete
EDTA-free protease inhibitor tablets from Roche, kaleido-
scope pre-stained protein markers from BioRad, MSH2
polyclonal antisera from Santa Cruz and plasmid-safe ATP-
dependent DNase from Epicentre. Other reagents were of the
highest grade obtainable.
Cell lines and cell lysates
Human HeLa (ATCC no. CCL-2) and LoVo (ATCC no. CCL-
229) cell lines were grown in DMEMwith 10% (v/v) fetal calf
serum. Cell cytoplasmic extracts were prepared as detailed in
the repair assay (15).
Mitochondrial lysate preparation
The liver of a freshly killed male Wistar rat (200±250 g) was
removed and placed into cold MSE buffer (220 mM mannitol,
70 mM sucrose, 5 mM MOPS, pH 7.0, 2 mM EGTA), prior to
preparation and percoll puri®cation as previously reported
(16). All preparations were analysed for citrate synthase and
adenylate kinase activity and aliquots subjected to western
analysis with antibodies to glutamate dehydrogenase and actin
to con®rm minimal contamination. After puri®cation, mito-
chondria were washed thoroughly in isotonic EDTA-free
buffer, and were lysed essentially as for the cytoplasmic
extracts, with an additional liquid nitrogen freeze/thaw before
homogenisation to promote bursting. Protein concentrations of
the lysates were calculated (Bradford) before snap freezing in
liquid nitrogen and storage in small (250±500 mg) aliquots at
±80°C.
Preparation of heteroduplexes
Heteroduplex was prepared as reported by Thomas et al. (15).
In brief, bacteriophage M13mp2 was propagated in the E.coli
strain NR9099 and both the replicative form (RF) and
single-stranded positive-strand viral DNA collected. Nicked
double-stranded RF DNA was degraded by the addition of
plasmid-safe DNase (Epicentre) and the intact RF digested
with AvaII or Bsu36I. Linearised RF was melted in the
presence of single-stranded viral DNA carrying the desired
mutation and the mixture left to anneal. Heteroduplex
containing a mismatch with a ¯anking nick either 3¢ or 5¢ to
the mismatch was therefore generated, depending on which
restriction enzyme was used. The heteroduplex was puri®ed
on a 0.8% agarose gel followed by electroelution and dialysis
to concentrate the sample.
Mismatch repair assays
Each sample (total volume 25 ml) contained: 30 mM HEPES
pH 7.8; 15 mM sodium phosphate pH 7.5; 7 mMMgCl2; 4 mM
rATP; 200 mM each rCTP, rGTP, rUTP; 100 mM each dATP,
dCTP, dGTP and TTP; 40 mM creatine phosphate; 100 mg/ml
creatine phosphokinase; 1 fmol (5 ng) puri®ed heteroduplex
substrate DNA; and 50 mg of crude cytoplasmic or mito-
chondrial lysate. The reaction was incubated for 20 min at
37°C, then terminated by the addition of a STOP mix [®nal
concentrations of 2 mg/ml Proteinase K, 2% (w/v) SDS and
50 mM EDTA] and re-incubation at 37°C for 60 min. The
substrate was recovered by ammonium acetate precipitation
with 0.71 mg/ml tRNA as carrier, a chloroform extraction, and
re-precipitation with isopropanol. DNA was resuspended in
5 ml of double-distilled water. When present, aphidicolin was
added to a ®nal concentration of 120 mM. In the competition
experiments, 1 pmol (10003 molar excess) of either homo- or
heteroduplex was used.
Recovered DNA was electroporated into NR9162 bacteria
(25 mF, 400 W, 2010 V/cm) and plated with a host strain,
CSH50, onto minimal media with X-Gal (70 mg/ml) and IPTG
(1 mM). Plaques were scored after at least 16 h incubation at
37°C.
ATP experiments
Samples were prepared as above, unless stated. When ATP
sulfurylase was used, the ATP-regenerating system was
omitted, but included crude lysate, 2.5 mM guanosine 5¢-
monophosphate (GMP) and 10 mM Na2MoO4. ATP sulfuryl-
ase was added to a concentration of 25 mg/ml and the samples
incubated at 37°C for 30 min. Substrate heteroduplex was
added and the assay allowed to proceed as normal. As control,
all buffer components were added in the absence of the ATP
sulfurylase.
Competitor duplex preparation
A 789 bp fragment of human mtDNA spanning nucleotides
367±1155 was PCR-ampli®ed from DNA isolated from two
®broblast cell lines encoding either the standard sequence or
carrying the A606G polymorphism (17). PCR product from
the standard sequence was used as homoduplex competitor
after puri®cation. For the heteroduplex competitor generation,
each DNA preparation was ampli®ed using one biotinylated
primer and one unbiotinylated primer such that the unbio-
tinylated strands contained a G and T, respectively. PCR
products were retained with magnetic streptavidin beads
(Dynabeads), and the unbiotinylated strands recovered (fol-
lowing the manufacturer's recommendation) and annealed to
give a GT heteroduplex.
Scoring and statistical analysis
Recovered substrate was plated to give approximately
100±400 plaques per 9 cm dish, with two dishes per sample
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per experiment. In all cases, experiments were repeated at
least three times. In most cases, scoring was performed blind;
plaques were scored and the results used to generate repair
percentages. Sample variance for this assay has been reported
at 10% (15). Two-tailed T-test analyses were performed,
assuming a normal distribution for both sample populations.
MSH2 western blot
Crude lysates (7.5±30 mg) were sonicated, boiled for 3 min and
separated through a 7.5% (w/v) SDS±PAGE at 30 mA for
150 min or until the ~50 kDa marker reached the bottom of the
gel. Gels were either stained with Coomassie brilliant blue dye
and photographed, or transferred onto PVDF membrane
[25 mM Tris pH 8.55, 200 mM glycine and 20% (v/v)
methanol] for 18 h at 30 V. Membranes were blocked in 13
TBS-T, 5% (w/v) milk powder for 1 h, then incubated with a
rabbit polyclonal anti-MSH2 antibody in blocking buffer for
3 h at room temperature. After washing, blots were incubated
with HRP-conjugated anti-rabbit secondary antibody in 13
TBS-T, 0.5% (v/v) milk powder (1 h). Blots were washed 53
in TBS-T and exposed to X-ray ®lm following addition of
ECL-PLUS reagent as recommended. Murine liver lysates
used as controls were prepared essentially as nuclear lysates in
(18).
RESULTS
The mismatch repair assay uses the analysis of plaque colour
to calculate the percentage repair of nicked heteroduplex
substrate after treatment with various cellular lysates and
bacterial transfection. The substrates contain various mis-
matches in the blue/white reporter gene b-galactosidase.
When the mismatch repair-de®cient E.coli strain NR9162
(MutS) is transfected and plated in the presence of IPTG and
X-Gal to allow blue/white scoring, unrepaired heteroduplex
gives rise to plaques of mixed blue and clear (white)
coloration. Repaired heteroduplex forms plaques of a single
(pure-burst) colour. In the following experiments, GT sub-
strates (5¢ and 3¢ nicked) give a wild-type (blue) phenotype
after nick-directed repair, and form clear plaques if repair is
directed to the opposite strand. The GG substrate is nick-
directed to repair to clear (mutant phenotype). Repair is
calculated as (1 ± the ratio of the percentages of mixed
burst plaques obtained from treated and untreated `mock'
substrates) and is expressed as a percentage.
Lysate from percoll-puri®ed rat mitochondria repairs a
GT mismatch
Mitochondria were obtained from male Wistar rat livers and
puri®ed by percoll gradient centrifugation as detailed in
Materials and Methods. Following lysis, the extract was used
to test whether mitochondria possessed mismatch repair
capability. HeLa cytoplasmic lysate was used as a positive
control to de®ne ef®cient repair, and cytoplasmic lysate
derived from the MMR-de®cient human cell line LoVo
represented a negative control. The GT substrate heteroduplex
was tested ®rst as this mismatch is repaired ef®ciently by
extracts from many species. The percoll-puri®ed rat mito-
chondrial lysate (designated `Percoll') shows 29 6 2% repair
ef®ciency for the GT-mismatched heteroduplex carrying a
nick 3¢ to the T (GT3¢). In comparison, the HeLa-positive
lysate was 65 6 3% repair ef®cient, with the negative control
LoVo lysate giving 5 6 2.5% repair (Fig. 1A). For the GT5¢
substrate, ®gures were similar; the Percoll mitochondrial
lysate supported 25.5 6 2% repair, with HeLa and LoVo
levels being, respectively, 636 1% and 76 0.5%. LoVo has a
deletion in the MSH2 gene encompassing exons 3±8 (19) and
is therefore mismatch repair de®cient. Comparisons of repair
ef®ciencies for the Percoll and the LoVo lysate returned a
highly signi®cant P-value of 5 3 10±4. Nuclear repair in the
assay is dependent on the concentration of repair proteins
(E. Matheson, unpublished data). As the proteins used by the
mitochondrial lysate have not been elucidated, the lower level
of Percoll repair may be due either to a lower concentration of
repair proteins in the lysate, or an inherently lower ef®ciency
of repair.
Interestingly, although nuclear repair is strongly nick-
directed, leading to a large excess of blue plaques over clear
for both GT substrates, mitochondrial repair gives approxi-
mately equal amounts of blue and clear pure-burst plaque
Figure 1. Repair activity in mitochondrial lysate. Nicked heteroduplex tem-
plate carrying a single mismatch (either GT5¢ or GT3¢) was prepared and
MMR assays performed with HeLa whole cell and percoll-puri®ed rat liver
mitochondrial lysate (`Percoll') as detailed in Materials and Methods.
Following transfection, resultant plaques were scored as mixed or pure burst
and the repair ef®ciency calculated. P-values for the statistical comparisons
are shown. (A) Mitochondrial lysate repairs GT heteroduplexes. Repair
activity is compared between MMR-pro®cient (HeLa) and -de®cient (LoVo)
cytoplasmic lysates and rat mitochondrial lysate (Percoll). For the GT3¢:
HeLa replicates, n = 6, total plaques counted, t = 2740; Percoll, n = 6,
t = 2873; LoVo, n = 3, t = 1599. For the GT5¢: HeLa, n = 6, t = 2751;
Percoll, n = 6, t = 837; LoVo, n = 3, t = 570. (B) Mitochondrial lysate
shows no strand bias for repair. The ratio of blue to clear pure burst plaques
indicates strand bias, as is demonstrated by the HeLa lysate. The mock that
represents the untreated heteroduplex shows no signi®cant difference when
subjected to repair by the mitochondrial lysate. Data is derived from the
same experiments as (A). (C) Aphidicolin does not impair repair activity in
mitochondrial lysate. Aphidicolin (120 mM), an inhibitor of nuclear poly-
merases a, d and e, was added to various lysates and repair of the GT3¢
heteroduplex was measured. Data is from three separate experiments.
HeLa 6 aphidicolin, P = 0.005; Percoll 6 aphidicolin, P =0.975.
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(Fig. 1B). When tested against the blue to clear ratios
produced by the mock samples, to which no lysate is added,
the bias exhibited by Percoll lysates were not signi®cantly
different (P-values of 0.95 and 0.27 for GT5¢ and GT3¢,
respectively).
Aphidicolin is an inhibitor of the major nuclear DNA
polymerases a, d and e, but has no effect on the mtDNA
polymerase g. It was important to test whether this mismatch
repair activity was mitochondrial or whether the lysate had
been contaminated by other polymerases during sub-
fractionation. Mismatch repair in HeLa cell extracts has
been shown to be aphidicolin-sensitive when using a similar
genetic read-out assay (20). Further studies suggest the active
polymerase is a rather than b, d or e (21). Thus, aphidicolin
should only allow repair using polymerase g, with perhaps a
small amount of bacterially derived resynthesis. Repair of
GT3¢ by HeLa lysate drops to below 10%, whereas Percoll
repair is unaffected by aphidicolin (Fig. 1C, P-values,
respectively, 0.005 and 0.975).
Repair is EDTA-sensitive
EDTA, which chelates divalent cations, is routinely used in
mitochondrial preparation; however, the EDTA sensitivity of
the mismatch repair assay is well attested, due to the absolute
requirement for magnesium (21). Percoll lysates were pre-
pared with and without EDTA to a concentration of 1.5 mM
(the EDTA levels present after typical mitochondrial isol-
ation). After dilution of lysate in the assay reaction, ®nal
concentrations ranged from 150 to 200 mM. As predicted,
EDTA reduced both HeLa and Percoll repair activities of GT3¢
(Fig. 2) to 5±10%, close to that recorded in the LoVo control.
A GG mismatch is also repaired
Very short patch repair activities have been reported. These
activities often involve MutY-like proteins and show a
preference for GT or GA mismatches (22,23). Although
these activities do show biased repair to GC, it is possible that
a related activity is responsible for the GT repair in the
mitochondrial lysate. To test this, a different substrate was
constructed from a phage derivative carrying a different
mutation in the b-galactosidase gene. The new heteroduplex
contained a GG mismatch with a nick 5¢ to this site. This GG5¢
mismatch was repaired with a similar ef®ciency to the GT
substrates, 33 6 2.5%, compared to 58 6 2% for the HeLa
control (Fig. 3). Again, repair bias was similar to the mock,
although in this case the mock exhibited a pre-existing bias
towards clear plaques. Nonetheless, mock/percoll bias was
statistically similar, matching the GT substrates. Thus, repair
activity in the mitochondrial lysate showed little bias towards
a GT or GG mismatch and, strikingly, did not show any nick-
directed bias in repair, as compared to the unrepaired substrate
bias.
Repair activity is not due to nick translation
As the repair activity exhibited by mitochondrial lysate does
not show any strand bias, it is a formal possibility that the
assay is merely measuring nick translation from nicks close to
the mismatch introduced randomly during incubation of the
substrate with the lysate. To our knowledge, nick translation
activity of mammalian DNA polymerase g has not been
reported. However, it is still important to try and exclude this
possibility.
Nick translation does not require ATP. Therefore, to test the
ATP-dependence of the mitochondrial activity, samples were
prepared in which both ATP and its regenerating system were
omitted (Table 1). As crude mitochondrial lysate may contain
signi®cant ATP levels, samples were also treated with ATP-
sulfurylase to remove all endogenous ATP (24). When lysates
were forced to attempt repair without ATP, the repair
capability from both nuclear and mitochondrial lysates was
severely reduced, although the variability was greater between
replicates than those for the basic assay (Table 1). Since the
sulfurylase needs molybdate as a co-factor, which could
adversely affect repair, two types of controls were performed.
The ®rst was a buffer control without sulfurylase (SB, Table 1).
Second, after the lysates were ATP-depleted by sulfurylase,
ATP was replenished to former levels (4 mM, + sulfurylase +
ATP, Table 1). In both cases, signi®cant levels of repair were
attained; for the GT5¢ substrate: HeLa +/± ATP P = 6.1 3
10±5; Percoll +/± ATP P = 0.00172, where + ATP denotes
repair by lysate untreated with sulphurylase (normal repair).
Adding competitor heteroduplex reduces repair
As a separate test to determine whether nick translation or
mismatch repair was responsible for resolution of the substrate
heteroduplex, competitor homo- and heteroduplexes were
added to the assay in excess of the substrate. A 789 bp
Figure 2. Mitochondrial repair activity is highly sensitive to EDTA. EDTA
sensitivity of repair for both nuclear and mitochondrial lysates was assessed
on the GT5¢ heteroduplex. Data is from three separate experiments. A con-
centration of EDTA much lower than is often used for isolating mitochon-
dria is shown to have a severely inhibitory effect on repair activity. HeLa 6
EDTA (200 mM), P = 0.005; Percoll, 6 EDTA, P = 0.0035.
Figure 3. A GG5¢ mismatch is also repaired. Repair activities (A) and
strand bias (B) are shown for a GG5¢ heteroduplex in HeLa and Percoll
lysates (50 mg). As shown for the GT mispair, GG is also repaired by the
mitochondrial lysate. Data is accumulated from four separate experiments:
mock, t = 2102; HeLa, t = 2288; Percoll, t = 2084. T-test analysis for strand
bias: mock/HeLa, P = 0.012; mock/Percoll, P = 0.64.
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heteroduplex incorporating a single GT mismatch was made
along with the corresponding GC homoduplex. A 1000-fold
molar excess of either species was added to samples in an
attempt to sequester mitochondrial proteins speci®cally
responsible for mismatch recognition. The addition of
heteroduplex had a marked effect on both HeLa and Percoll
repair activity with the GT3¢ substrate. For each lysate, repair
diminished below LoVo negative levels (Fig. 4). Adding
homoduplex to the same excess also reduces activity,
particularly with HeLa lysate, although this is not statistically
signi®cant. This decrease in activity may have been due to
partial sequestration of the scanning component of MMR in
the HeLa lysate, but the differential result between HeLa and
Percoll lysates is again consistent with a different mechanism
of MMR.
MSH2 is not detectable in rat liver mitochondrial lysates
Since the above data strongly suggest the presence of
mismatch repair in rat mitochondria, the logical progression
was to investigate whether any common mismatch protein
isoforms are detectable in the Percoll lysate. Since MSH2, an
essential mismatch repair protein, has been reported in rat
liver mitochondrial preparations (25), western analysis of the
lysates used in the above repair assays was carried out using a
polyclonal anti-hMSH2 antibody that detects rat, mouse and
human MSH2. Repeated testing showed MSH2 in HeLa
cytoplasmic lysates, with LoVo giving no signal, as expected
(26). However, whilst rat and murine liver whole cell extract
showed a cross-reacting species of the expected mass,
percoll-puri®ed rat mitochondrial lysate did not (Fig. 5).
DISCUSSION
The results set out above are consistent with a mismatch repair
activity in mammalian mitochondria. Percoll-puri®ed rat liver
mitochondria show a highly reproducible and signi®cant
repair capability with both GT and GG mismatches.
Consistent with these observations, our preliminary data
show a similar repair activity in human HeLa mitochondrial
lysates (data not shown). Several experiments indicate this
activity is unlikely to be due to nuclear contamination. First,
inhibition of most nuclear polymerases by aphidicolin gave
no decrease in repair activity. Second, using a variety of
markers, contamination of the mitochondrial lysate by other
components was negligible. Third, repair activity did not show
nick-dependent strand or base repair bias, unlike other known
activities. Repair was extremely sensitive to EDTA and it was
important to wash mitochondrial preparations in isotonic
EDTA-free buffer prior to preparation of the lysate.
Mitochondrial repair is not directed to the nicked strand like
its nuclear counterpart; this suggests that the activity is either
unbiased, or the method of discrimination is not revealed by
this assay. Potentially, nick translation could account for
unbiased repair, especially as the mitochondrial lysate exhibits
appreciable nuclease activity. Two observations refute this.
First, both polymerase and nuclease activities in nick trans-
lation are ATP-independent, yet the repair activity in
mitochondria is strongly ATP-dependent. Second, the addition
of linear competitor DNA carrying a mismatch strongly
inhibits mitochondrial MMR ef®ciencies whereas the fully
complementary DNA does not.
What is the mechanism of mitochondrial MMR? At present,
our data is unable to provide the answer, but it does give some
clues. Several DNA glycosylases have been identi®ed in
mammalian mitochondria that function in the removal of base
adducts such as oxidised purines [hOGG1, hMYH1 (27)] or
thymine glycol [mtTGendo (28)] and uracil [UNG1 (29)].
These glycosylases are postulated to function by short patch
Table 1. Mitochondrial MMR requires ATP
Lysate 6 components % Repair heteroduplex template
GT5¢ GT3¢
HeLa 67.8 6 5 (n = 7) 62.1 6 3.8 (n = 7)
HeLa + SBa 74.9 (n = 2) ND
HeLa ± ATPb ±8.4 6 10.1 (n = 3) ±4.1 6 11.3 (n = 3)
HeLa + sulfurylase +ATPc 34.9 6 3.8 (n = 6) ND
Percoll 28.7 6 2.4 (n = 8) 26.1 6 3.1 (n = 8)
Percoll + SBa 23.1 (n = 2) ND
Percoll ± ATPb ±10.2 6 14.1 (n = 3) 0.85 6 2.9 (n = 3)
Percoll + sulfurylase + ATPc 29.7 6 4.1 (n = 3) ND
ND, not determined.
aSB indicates that activity was assessed after the addition of sulfurylase
buffer without the addition of the enzyme.
bConditions identical to those in footnote a, except for the addition of ATP
sulfurylase, and the non-inclusion of ATP in reaction buffers.
cConditions identical to those in footnote b, but following sulfurylase
treatment the ATP is replenished to 4 mM.
Figure 4. Mitochondrial repair activity is inhibited by competitor hetero-
duplex. Repair activities of the GT5¢ substrate were measured after supple-
menting various lysates with either a 789 bp competitor hetero- or
homoduplex. Activities of both lysates are substantially inhibited by the
addition of the heteroduplex (1000-fold excess), whilst the homoduplex
had only a marginal effect on mitochondrial repair. Data was from three
separate experiments. T-test statistical analysis: HeLa/homoduplex P =
0.060, HeLa/heteroduplex P = 0.001; Percoll/homoduplex P = 0.549,
Percoll/heteroduplex P = 0.017.
Figure 5. MSH2 is not detectable in rat liver mitochondria. Whole cell
lysates and cellular fractions were prepared, separated on a 7.5% polyacryl-
amide denaturing gel, and transferred to a solid support as detailed in
Materials and Methods. Polyclonal antisera were used to detect MSH2 and
bound antibody visualised with ECL reagents (Amersham). Lane 1, HeLa
cell lysate (7.5 mg); lane 2, LoVo cell lysate (15 mg); lane 3, rat liver cell
lysate (15 mg); lanes 4 and 5, puri®ed rat liver mitochondria (7.5 and 30 mg,
respectively); lane 6, murine liver cell lysate (7.5 mg); lane 7, murine
nuclear extract (7.5 mg). Relevant molecular weight size markers (kDa) are
shown to the left of the image.
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BER. To date, there has been no report of NER in mammalian
mitochondria, an observation based on the dif®culties in
repairing large DNA lesions in mtDNA (30). Although it is
tempting to suggest that the BER pathway may be intimately
involved in mismatch resolution, the absence of repair bias is
surprising. In all cases, mitochondrial BER pathways show a
clear bias to removing the unwanted base or adduct.
Furthermore, although the GT mismatch is likely to be
recognised by the BER machinery, the GG mismatch would
not be expected to be recognised and resolved with equal or
greater ef®ciency than the GT. Also, the BER pathway needs
no ATP until the ®nal ligation step, yet the mitochondrial
lysate repair is largely ATP-dependent. A number of mis-
match proteins possess ATPase domains, as does DNA
helicase, used to unwind the DNA prior to degradation and
resynthesis of the lesional strand. It is therefore possible that a
small percentage of the repair in the mitochondrial lysate is
either BER or nick translation; however, the bulk of repair is
clearly via another method.
So, does mitochondrial MMR utilise homologues of the
classic MutHLS repair system? MSH1 clearly has a
mitochondrial function in yeast, but no homologue is apparent
in higher eukaryotes. It is possible that some of the MutL or
MutS homologues known to function in MMR may pick up
mitochondrial targeting sequences by alternative transcription
initiation or splicing, as has been reported for the UNG gene
product (29). The most central player is MSH2, which has
apparently been identi®ed in rat mitochondrial lysate (25). As
reported here, we were unable to detect MSH2 in our rat liver
lysates. Protease inhibitors were used in preparing these
lysates and western analysis using several mitochondrial
markers was unable to detect any evidence of proteolytic
degradation. Irrespective, the same lysate clearly demon-
strated MMR activity. So, although we cannot conclude that
mitochondrial MMR is MSH2-independent, if a mitochondrial
form of MSH2 exists, it must be present at a low level in the
organelle.
If mitochondrial MMR is MSH2-independent, why is there
such low-level activity in LoVo cell lysate, which is only
known to carry an msh2 mutation? In mammals, MSH2 forms
two heterodimers: with MSH6 it forms MutSa, which repairs
base±base mismatches, whilst with MSH3 (MutSb) it repairs
short loops. When MSH2 protein is absent, both MSH3 and
MSH6 protein partners are unstable and rapidly degraded (31).
Thus, LoVo lysates are functionally lacking in both nuclear
MutS complexes; however, a mitochondrially targeted iso-
form of MSH3 that worked in the absence of MSH2 would not
be predicted to be destabilised. Whole cell lysate is used at
similar concentrations to the mitochondrial lysates for our
assays. Assuming standard 5-fold protein enrichment if
mitochondria were puri®ed from LoVo cells, it is interesting
to note that the apparent low level of activity in the LoVo
lysate would then be increased to the similar levels demon-
strated in rat liver mitochondria. Therefore, it is possible that
the minimal activity in the LoVo cells could be due to
mitochondrial MMR protein in the lysate.
Whatever mechanism is postulated to explain mitochondrial
MMR, it is unusual that the repair shows no strand bias in our
assay. Why would mitochondria possess a MMR activity that
does not show any strand bias? If mitochondria were unable to
bias repair, an incorrectly added nucleotide could become
mutagenic, acting as a template to drive mutation of the
mismatch. This could explain the signi®cantly high level of
mtDNA mutation as compared to nuclear DNA (32).
However, why retain such an activity when the mismatch
would be resolved after a single round of replication, without
the need for any form of repair? One intriguing explanation is
that the MMR activity in mitochondria has not been retained
to repair single base mismatches, but for the resolution of
loops. The number of short repeat sequences in the
mitochondrial genome is remarkable (see MITOMAP at
http://www.mitomap.org). It is well known that large deletions
of the genome are common, and believed to be nucleated at
repeat sequences that cause slipped replication. Small dele-
tions are relatively uncommon. Mitochondrial MMR may
have been retained to repair short palindrome-containing loop
mismatches, which must also occur during replication but
rarely cause deletions. Taghian et al. (33) have demonstrated
such an activity in the nucleus of a mutant CHO cell line. They
report that short loops containing palindromic repeats are
repaired and are retained, irrespective of nicks, whilst large
loops are lost from a heteroduplex substrate. This cell line was
able to repair single base mismatches at lower frequency and is
reported to be MSH2-de®cient. The enzyme responsible for
this repeat retention is currently unknown but a mitochondrial
homologue may be important to retain the integrity of the
mammalian mitochondrial genome.
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